FdaApplication
ANDA 207497
Identifiers
- fda_app_no: ANDA207497
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2018-11-30 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE;ORAL |
| LAMOTRIGINE | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
| LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE;ORAL |
| LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE;ORAL |
| LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
6 products